mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-07 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.0006 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0007 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0007 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.003 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.003 |